Roderick McPhee
Moderna Therapeutics (United States)
ORCID: 0000-0003-4134-7767Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 3 papers. Top paper: “Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized Trial”.
Ximena Norero, Marisa Márcia Mussi‐Pinhata, Kathia Luciani, Ignacio Salamanca de la Cueva, Javier Díez‐Domingo +36 more
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Kashif Ali, Gary Berman +10 more
Robert M. Jacobson, Susan A. Weston, Chun Fan, Roderick McPhee, Philip O. Buck +2 more